64
Views
0
CrossRef citations to date
0
Altmetric
Case Series

Rapid Response of Myasthenic Ocular Signs to IvIg Treatment

, &
Pages 249-252 | Received 20 Jun 2008, Accepted 08 Jul 2008, Published online: 08 Jul 2009

REFERENCES

  • Evoli A, Batocchi AP, Minisci C, Di Schino C, Tonali P. Therapeutic options in ocular myasthenia gravis. Neuromusc Dis. 2001; 11: 208–216
  • Victor M, Ropper AH. Myasthenia gravis and related disorders of the neuromuscular junction. Adams and Victor's Principles of Neurology, M Victor, AH Ropper, McGraw-Hill 2001; 1536–1547
  • Sommer N, Sigg B, Melms A, et al. Ocular myasthenia gravis: Response to long-term immunosuppressive treatment. J Neurol Neurosurg Psychiatry 1997; 62: 156–162
  • Keesey J. A treatment algorithm for autoimmune myasthenia in adults. Ann N Y Acad Sci. 1998; 841: 753–768
  • Arsura EL, Bick A, Brunner NG, Namba T, Grob D. High-dose intravenous immunoglobulin in the management of myasthenia gravis. Arch Intern Med. 1986; 146: 1365–1368
  • Cosi V, Lombardi M, Piccolo G, Erbetta A. Treatment of myasthenia gravis with high-dose immunoglobulin. Acta Neurol Scand. 1991; 84: 81–84
  • Fateh-Moghadam A, Wick M, Besinger U, Geursen RG. High-dose intravenous gammaglobulin for myasthenia gravis. Lancet 1984; 1: 848–849
  • Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Ann Neurol. 1997; 41: 789–796
  • Gajdos P, Outin H, Elkharrat D, et al. High-dose intravenous gammaglobulin for myasthenia gravis. Lancet 1984; 1: 406–407
  • Hilkevich O, Drory VE, Chapman J, Korczyn A. The use of intravenous immunoglobulin as maintenance therapy in myasthenia gravis. Clin Neuropharmacol. 2001; 24: 173–176
  • Horton RH, Manfredi AA, Conti-Tronconi BM. The “embryonic” γ subunit of the nicotinic acetylcholine receptor is expressed in adult extrinsic ocular muscles. Neurology 1993; 43: 983–986
  • Wang ZY, Okita DK, Howard J, Conta-Fine M. T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis. Neurology 1998; 50: 1045–1054
  • Kaminski HJ, Richmonds CR, Kusner LL, Mitsumoto H. Differential susceptibility of the ocular motor system to disease. Ann N Y Acad Sci. 2002; 956: 42–54
  • Yu Wai, Man CY, Chinnery PF, Griffiths PG. Extraocular muscles have fundamentally distinct properties that make them selectively vulnerable to certain disorders. Neuromuscul Disord. 2005; 15: 17–23

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.